- Pharmaceutical companies
- Europe
- Belgium
- Novartis
Novartis in Belgium
Addresses:
-
Novartis Pharma N.V., Rue du Trône 108, B-1050 Brussels, Belgium
Phone: 32 2 246 1975
Fax: 32 2 246 1996
-
Novartis Pharma NV, Medialaan 40, B-1800 Vilvoorde, Belgium
Phone: 32 2 246 1611
Fax: 32 2 246 1886
-
Sandoz NV, Medialaan 40, B-1800 Vilvoorde, Belgium
Phone: 32 2 722 9797
Fax: 32 2 722 9790
Other Novartis's locations around the world
-
Switzerland
-
Austria
-
Germany
-
Slovenia
-
Poland
-
France
-
Spain
-
Romania
-
Italy
-
United Kingdom
-
Ukraine
-
Russia
-
Serbia
-
Slovakia
-
Sweden
-
Belarus
-
Bulgaria
-
Croatia
-
Czech Republic
-
Denmark
-
Estonia
-
Finland
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Latvia
-
Lithuania
-
Luxembourg
-
Macedonia
-
Malta
-
Montenegro
-
Netherlands
-
Norway
-
Portugal
-
Albania
-
Bosnia & Herzegovina
Clinical Trials sponsored by Novartis
-
Novartis PharmaceuticalsHar inte rekryterat ännuAnti-neutrofila cytoplasmaantikroppar (ANCA) associerad vaskulit
-
Novartis PharmaceuticalsHar inte rekryterat ännuMultipel skleros, skov-remitterande
-
Novartis PharmaceuticalsHar inte rekryterat ännuReumatoid artrit | Systemisk lupus erythematosus | Sjögrens sjukdom
-
Novartis PharmaceuticalsHar inte rekryterat ännuFörhöjd Lp(a) och etablerad aterosklerotisk kardiovaskulär sjukdom
-
Novartis PharmaceuticalsRekryteringÅterfallande former av multipel sklerosSpanien
-
Novartis PharmaceuticalsRekrytering
-
Novartis PharmaceuticalsHar inte rekryterat ännu
-
Novartis PharmaceuticalsRekryteringMultipel skleros (MS)Frankrike
-
Novartis PharmaceuticalsHar inte rekryterat ännu
-
Novartis PharmaceuticalsRekrytering
About Novartis
Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.